table of contents table of contents

Current anti-doping in competitive sports is advocated for reasons of fair-play and …

Home » Biology Articles » Bioethics » Current anti-doping policy: a critical appraisal » References

- Current anti-doping policy: a critical appraisal

  1. [] 2007.

  2. [] 2007.

  3. Fost N: Banning Drugs in Sports: A Skeptical View'.

    Hastings Cent Rep 1986, 16:5-10.

  4. Mehlman MJ, Banger E, Wright MM: Doping in Sports and the Use of State Power.

    Saint Louis University Law Journal 2006, 15-73.

  5. Savulescu J, Foddy B, Clayton M: Why we should allow performance enhancing drugs in sport.

    Br J Sports Med 2004, 38:666-670. 

  6. Shapiro MH: 'The technology of perfection: performance enhancement and the control of attributes.

    Southern California Law Review 1991, 11-113. 

  7. Loland S: Fair play in sport a moral norm system. London, Routledge; 2002. [Ethics and sport]

  8. Simon RL: Fair play sports, values, and society. Boulder, Westview Press; 1991.

  9. Rankinen T, Perusse L, Rauramaa R, Rivera MA, Wolfarth B, Bouchard C: The human gene map for performance and health-related fitness phenotypes: the 2003 update.

    Med Sci Sports Exerc 2004, 36:1451-1469. 

  10. Booth FW, Fluck M, Tseng BS, Carson JA: Molecular and cellular adaptation of muscle in response to physical training.

    Acta Physiologica Scandinavica 1998, 162:343-350. 

  11. The Stockholm declaration [] 2006.

  12. Dennis C: Rugby team converts to give gene tests a try.

    Nature 2005, 434:260-260.

  13. Kennedy D: Here come the Olympics.

    Science 2004, 305:573. 

  14. Handelsman DJ: Designer androgens in sport: when too much is never enough. [] Sci STKE 2004, 2004:e41.

  15. Knight J: Drugs bust reveals athletes' secret steroid.

    Nature 2003, 425:752.

  16. [] 2007.

  17. DuRant RH, Rickert VI, Ashworth CS, Newman C, Slavens G: Use of multiple drugs among adolescents who use anabolic steroids.

    N Engl J Med 1993, 328:922-926. 

  18. Koch JJ: Performance-enhancing: substances and their use among adolescent athletes.

    Pediatr Rev 2002, 23:310-317. 

  19. Laure P: [Doping: epidemiological studies].

    Presse Med 2000, 29:1365-1372.

  20. Laure P, Lecerf T, Friser A, Binsinger C: Drugs, recreational drug use and attitudes towards doping of high school athletes.

    Int J Sports Med 2004, 25:133-138.

  21. Melia P, Pipe A, Greenberg L: The use of anabolic-androgenic steroids by Canadian students.

    Clin J Sport Med 1996, 6:9-14.

  22. Midgley SJ, Heather N, Best D, Henderson D, McCarthy S, Davies JB: Risk behaviours for HIV and hepatitis infection among anabolic-androgenic steroid users.

    AIDS Care 2000, 12:163-170. 

  23. Beullens M, Delanghe JR, Bollen M: False-positive detection of recombinant human erythropoietin in urine following strenuous physical exercise.

    Blood 2006, 107:4711-4713.

  24. Fost N: Ethical dilemmas in medical innovation and research: distinguishing experimentation from practice.

    Semin Perinatol 1998, 22:223-232. 

  25. Parkkari J, Kujala UM, Kannus P: Is it possible to prevent sports injuries? Review of controlled clinical trials and recommendations for future work.

    Sports Med 2001, 31:985-995.

  26. Pipe A: The adverse effects of elite competition on health and well-being.

    Can J Appl Physiol 2001, 26 Suppl:S192-S201.

  27. Junge A, Dvorak J: Soccer injuries : a review on incidence and prevention.

    Sports Med 2004, 34:929-938. 

  28. Jordan BD: Chronic traumatic brain injury associated with boxing.

    Semin Neurol 2000, 20:179-185.

  29. Banerjee R, Palumbo MA, Fadale PD: Catastrophic cervical spine injuries in the collision sport athlete, part 1: epidemiology, functional anatomy, and diagnosis.

    Am J Sports Med 2004, 32:1077-1087. 

  30. Tokish JM, Kocher MS, Hawkins RJ: Ergogenic aids: a review of basic science, performance, side effects, and status in sports.

    Am J Sports Med 2004, 32:1543-1553.

  31. Hartgens F, Kuipers H: Effects of androgenic-anabolic steroids in athletes.

    Sports Med 2004, 34:513-554.

  32. Ama PF, Betnga B, Ama M V, Kamga JP: Football and doping: study of African amateur footballers.

    Br J Sports Med 2003, 37:307-310.

  33. Thiblin I, Petersson A: Pharmacoepidemiology of anabolic androgenic steroids: a review.

    Fundam Clin Pharmacol 2005, 19:27-44.

  34. Medras M, Tworowska U, Jozkow P, Dumanski A, Dubinski A: Postoperative course and anabolic-androgenic steroid abuse -- a case report.

    Anaesthesia 2005, 60:81-84. 

  35. Alaranta A, Alaranta H, Holmila J, Palmu P, Pietila K, Helenius I: Self-Reported Attitudes of Elite Athletes Towards Doping: Differences Between Type of Sport.

    Int J Sports Med 2006, 27:842-6. 

  36. Voy R: Drugs, Sport and Politics. Champaign, Leisure Press; 1991.

  37. Schumacher YO, Ashenden M: Doping with artificial oxygen carriers: an update.

    Sports Med 2004, 34:141-150. 

  38. Parens E: Enhancing Human Traits: Ethical and Social Implications. Washington D.C., Georgetown University Press; 1998.

  39. Schweizer C, Saugy M, Kamber M: Doping Test Reveals High Concentrations of Salbutamol in a Swiss Track and Field Athlete.

    Clin J Sport Med 2004, 14:312-315. 

  40. Naranjo OJ, Centeno Prada RA, Carranza M M.D.: Use of beta2 agonists in sport: are the present criteria right?

    Br J Sports Med 2006, 40:363-366.

  41. Rohrbough JT, Altchek DW, Hyman J, Williams RJ III, Botts JD: Medial collateral ligament reconstruction of the elbow using the docking technique.

    Am J Sports Med 2002, 30:541-548.

  42. Gusfield JR: Symbolic crusade status politics and the American temperance movement. Urbana, University of Illinois Press; 1963.

  43. Parssinen M, Kujala U, Vartiainen E, Sarna S, Seppala T: Increased premature mortality of competitive powerlifters suspected to have used anabolic agents.

    Int J Sports Med 2000, 21:225-227.

  44. Gomez J: Use of performance-enhancing substances.

    Pediatrics 2005, 115:1103-1106.

  45. Miah A: Doping and the child: an ethical policy for the vulnerable.

    Lancet 2005, 366:874-876.

  46. Berlin B: Steroids. Building a better you?

    N J Med 1999, 96:49-51.

  47. Aitken C, Delalande C, Stanton K: Pumping iron, risking infection? Exposure to hepatitis C, hepatitis B and HIV among anabolic-androgenic steroid injectors in Victoria, Australia.

    Drug Alcohol Depend 2002, 65:303-308.

  48. Houlihan B: Anti-doping policy in sport: The politics of international policy co-ordination.

    Public Administration 1999, 77:311-334.

  49. [] 


  50. [] 


  51. Campos DR, Yonamine M, Moraes Moreau RL: Marijuana as doping in sports.

    Sports Med 2003, 33:395-399. 

  52. Wilber RL: Current trends in altitude training.

    Sports Med 2001, 31:249-265. 

  53. Space-tech at the Paralympics - Czyz takes Gold in 100 m sprint [] 


  54. Miah A, Eassom SB: Sport Technology: History, Philosophy & Policy. Research in Philosophy & Technology.. Oxford, Elsevier Science; 2002.

  55. Sheridan H, Pasveer B, Van Hilvoorde I: Gene-talk and sport-talk: A view from the radical middle ground.

    Eur J Sport Sc 2006, 6:223-230.

  56. Haisma HJ, de Hon O: Gene doping.

    Int J Sports Med 2006, 27:257-266.

  57. Franke WW, Berendonk B: Hormonal doping and androgenization of athletes: a secret program of the German Democratic Republic government.

    Clin Chem 1997, 43:1262-1279.

  58. Tuffs A: Doped East German athletes to receive compensation.

    BMJ 2002, 324:1544.

  59. Murray TH: The coercive power of drugs in sports.

    Hastings Cent Rep 1983, 13:24-30.

  60. Waddington I: Sport, Health and Drugs: A Critical Sociological Perspective. Leicester, E and FN Spon; 2000.

rating: 3.00 from 3 votes | updated on: 21 Oct 2008 | views: 11367 |

Rate article: